Results 31 to 40 of about 337,050 (372)
Frontiers in Oncology, 2022 Renal cancer is one of the most extensively studied human tumors today, with clear cell renal cell carcinoma accounting for approximately 80% of all cases.
Tiancheng Jiang +9 more
doaj +1 more source
Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
Journal of Clinical Oncology, 2022 PURPOSE To provide recommendations for the management of patients with metastatic clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic literature review to obtain evidence to guide treatment recommendations. RESULTS The
W. Rathmell +16 more
semanticscholar +1 more source
Oncogenic microRNAs characterization in clear cell renal cell carcinoma [PDF]
, 2015 A key challenge for the improvement of clear cell renal cell carcinoma (ccRCC) management could derive from a deeper characterization of the biology of these neoplasms that could greatly improve the diagnosis, prognosis and treatment choice. The aim of
BELLISSIMO, TERESA +8 more
core +2 more sources
Clear Cell Renal Cell Carcinoma: Local Recurrence and Bilateral Adrenal Metastases - A Case Report
Journal of the Belgian Society of Radiology, 2022 Introduction: Clear cell renal cell carcinoma is the most frequent type of renal cell carcinoma, which is often diagnosed incidentally in an advanced stage.
Eliza-Maria Popa +2 more
doaj +1 more source
International Journal on Biological Sciences, 2022 Inactive von Hippel-Lindau (VHL) is linked to metabolic reprogramming and plays pivotal roles in the pathogenesis of clear cell renal cell carcinoma (ccRCC).
Jiefeng Yang +13 more
semanticscholar +1 more source
A novel combination of triple metachronous malignancies of the kidney, oropharynx and prostate. A case report [PDF]
, 2015 Synchronous or metachronous malignancies are a rare event, with an incidence rate that increases with age. The present study reports the case of a 70-year-old Caucasian male who was referred to the outpatient office of the Urology Unit, Sapienza ...
Carbone, Antonio +6 more
core +1 more source
Journal of Clinical Oncology, 2022 PURPOSE To assess the efficacy and safety of cabozantinib plus nivolumab in a phase II trial in patients with non–clear-cell renal cell carcinoma (RCC).
Chung-Han Lee +17 more
semanticscholar +1 more source
An Overview of Epigenetics in Clear Cell Renal Cell Carcinoma
In Vivo, 2023 Renal cell carcinoma (RCC) represents a heterogenous group of cancers with complex genetic background and histological varieties, which require various clinical therapies. Clear cell RCC represents the most common form of RCC that accounts for 3 out of 4 RCC cases.
STAMATIKI GRAMMATIKAKI +7 more
openaire +2 more sources
Tumor Biology, 2017 Long noncoding RNA urothelial carcinoma-associated 1 has previously played important roles in cancer. However, its role is still unknown in clear cell renal cell carcinoma.
Yang Wang +4 more
doaj +1 more source
Di-san junyi daxue xuebao, 2019 Objective To explore the effect of tripartite motif-containing protein 2 (TRIM2) on the proliferation, migration and stemness of clear cell renal clear carcinoma.
LUO Xing +4 more
doaj +1 more source